Copyright © 2004 by the European Society of Cardiology.
Clinical research
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction
a Experimental Cardiovascular Research Unit, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden
b Division of Cardiovascular Epidemiology, Institute for Environmental Medicine, Karolinska Institute, Stockholm, Sweden
c Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden
d Center of Metabolism and Endocrinology, Center of Infectious Medicine, Karolinska University Hospital, Huddinge, Sweden
e Division of Clinical Chemistry and Blood Coagulation, Department of Surgical Sciences, Karolinska Institute, Stockholm, Sweden
f Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
Received January 28, 2004;
revised April 20, 2004;
accepted May 5, 2004
* Corresponding author. Tel.: +46-8-517 73207; fax: +46-8-31 3147
zhong-qun.yan{at}cmm.ki.se
See page 1378 for the editorial comment on this article1
Aim Toll-like receptor 4 (TLR4) is a receptor for bacterial lipopolysaccharide (LPS) and heat shock protein essential for innate immunity. Recent studies imply that TLR4 polymorphisms might affect atherogenesis. In this study we investigated the impact of LPS-hypo-responsive TLR4 variants on the risk of myocardial infarction (MI).
Methods and results Using TaqMan PCR technology, we determined the prevalence of the Asp299Gly and Thr399Ile polymorphisms in the TLR4 gene, and their association with MI in a study of 1213 survivors of a first MI and 1561 controls from the Stockholm region.
The frequency was 0.096 for carriers of both 299Gly and 399Ile, and 0.006 for carriers of 399Ile alone. Carriers of both 299Gly and 399Ile were more frequent among the male cases than the male controls (10.7% vs 7.9%, 
). Compared with wild-type carriers, men with the 299Gly and the 399Ile TLR4 genotype had an increased risk of MI (OR [95% CI]: 1.4 [1.0;1.9]) whereas no association was observed for women. Furthermore a synergistic interaction was found between the TLR4 polymorphism and smoking in men.
Conclusion The association found between TLR4 genotype and risk of MI suggests that TLR4 genetic variants could potentially affect the susceptibility to MI and that TLR4-mediated innate immunity is implicated in the pathogenesis of MI.
Key Words: Toll-like receptor 4 • Myocardial infarction • Immune system • Single nucleotide polymorphism • Genetics
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- On the interpretation of genetic association studies
- Sekar Kathiresan, Christopher Newton-Cheh, and Robert E. Gerszten
EHJ 2004 25: 1378-1381.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  W. Chao Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Malarstig, S. Sigurdsson, P. Eriksson, G. Paulsson-Berne, U. Hedin, L. Wallentin, A. Siegbahn, A. Hamsten, and A.-C. Syvanen Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hermann Review: Variability of host pathogen interaction Innate Immunity, August 1, 2007; 13(4): 199 - 218. [Abstract] [PDF]
|
|
|
|
|
|
Z.-q. Yan Regulation of TLR4 Expression Is a Tale About Tail. Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2582 - 2584. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koch, P. Hoppmann, A. Pfeufer, A. Schomig, and A. Kastrati Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population Eur. Heart J., November 1, 2006; 27(21): 2524 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Keavney Toll the bell for another genetic association? Eur. Heart J., November 1, 2006; 27(21): 2489 - 2490. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rallabhandi, J. Bell, M. S. Boukhvalova, A. Medvedev, E. Lorenz, M. Arditi, V. G. Hemming, J. C. G. Blanco, D. M. Segal, and S. N. Vogel Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling J. Immunol., July 1, 2006; 177(1): 322 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Harari, P. Alcaide, D. Ahl, F. W. Luscinskas, and J. K. Liao Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway Circ. Res., May 12, 2006; 98(9): 1134 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Mandal, A R Afzal, S J D Brecker, J Poloniecki, Q Xu, and M Jahangiri Association of serum soluble heat shock protein 60 with toll-like receptor 4 polymorphism and severity of coronary artery disease. Heart, May 1, 2006; 92(5): 683 - 685. [Full Text] [PDF]
|
|
|
|
|
|
S. N. Vogel, A. A. Awomoyi, P. Rallabhandi, and A. E. Medvedev Mutations in TLR4 signaling that lead to increased susceptibility to infection in humans: an overview Innate Immunity, December 1, 2005; 11(6): 333 - 339. [Abstract] [PDF]
|
|
|
|
|
|
G. K. Hansson and K. Edfeldt Toll To Be Paid at the Gateway to the Vessel Wall Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1085 - 1087. [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Balistreri, G. Candore, G. Colonna-Romano, D. Lio, M. Caruso, E. Hoffmann, C. Franceschi, and C. Caruso Role of Toll-like Receptor 4 in Acute Myocardial Infarction and Longevity JAMA, November 17, 2004; 292(19): 2339 - 2340. [Full Text] [PDF]
|
|
|
|
|
|
K. S. Michelsen, T. M. Doherty, P. K. Shah, and M. Arditi TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis J. Immunol., November 15, 2004; 173(10): 5901 - 5907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kathiresan, C. Newton-Cheh, and R. E. Gerszten On the interpretation of genetic association studies Eur. Heart J., August 2, 2004; 25(16): 1378 - 1381. [Full Text] [PDF]
|
|